2 June 2010 – AGM statement

At today’s AGM, the chairman of this woundcare products business will confirm that the strong trading seen at the start of the year has continued during the first half and substantially ahead of the same period last year.  The group continues to broaden its global distribution network with further partners added in the US (including the largest pharmaceutical distributor in North America), while regulatory approval for the full product range has been received in both Canada and Japan.  The Corpora business acquired last October has been successfully integrated and is performing strongly, while the move to the new facility at Winsford continues on schedule and on budget.  The group also intends to pay a maiden dividend for the full year – the shares remain ATTRACTIVE.